A

What Should Investors Know About Agilent Technologies (A) Stock?

Large-cap industrials company Agilent Technologies has moved 1.4% this evening, reaching $110.51 per share. In contrast, the average analyst target price for the stock is $136.88.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company is based in the United States. Agilent Technologies currently returns an annual dividend yield of 0.8%.

What to Consider if You Are Thinking of Buying Agilent Technologies:

  • Agilent Technologies has moved -12.0% over the last year.

  • A has a forward P/E ratio of 19.4 based on its EPS guidance of 5.7.

  • Over the last 6 years, earnings per share (EPS) have been growing at a compounded average rate of 11.7%.

  • The company has a price to earnings growth (PEG) ratio of 2.53.

  • Its Price to Book (P/B) ratio is 5.82

Agilent Technologies Has Irregular Cash Flows

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2022-12-21 1,312,000 -291,000 1,603,000 -4.13
2021-12-17 1,485,000 -187,000 1,672,000 60.92
2020-12-18 921,000 -118,000 1,039,000 -11.65
2019-12-19 1,021,000 -155,000 1,176,000 -6.89
2018-12-20 1,087,000 -176,000 1,263,000 18.59
2017-12-21 889,000 -176,000 1,065,000

Agilent Technologies's free cash flows have a decent average of $1.3 Billion over the last 6 years, but they are highly variable since their coefficient of variability is 2872420268.0%. The compounded average growth rate over this period is 0.0%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS